Eli Lilly and Company (DE) revenue breakdown overview

Eli Lilly and Company (DE) revenue for the last year amounted to 43.51 B EUR, the most of which — 43.51 B EUR — came from its highest performing source at the moment, Human Pharmaceutical Products, the year earlier bringing 30.92 B EUR. The greatest contribution to the revenue figure was made by United States — last year it brought Eli Lilly and Company (DE) 29.34 B EUR, and the year before that — 19.74 B EUR.